Authors:
McGrath, LT
McCall, D
Hanratty, CG
Brennan, S
Devine, A
McCauley, DF
Silke, B
Elborn, S
Citation: Lt. Mcgrath et al., Individuals with cystic fibrosis do not display impaired endothelial function or evidence of oxidative damage in endothelial cells exposed to serum, CLIN SCI, 101(5), 2001, pp. 507-513
Authors:
McVeigh, GE
Allen, PB
Morgan, DR
Hanratty, CG
Silke, B
Citation: Ge. Mcveigh et al., Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis, CLIN SCI, 100(4), 2001, pp. 387-393
Citation: Cg. Hanratty et al., Hyperhomocysteinaemia in young adults is not associated with impaired endothelial function, CLIN SCI, 100(1), 2001, pp. 67-72
Authors:
Silke, B
Hanratty, CG
Veres, SM
Riddell, JG
Citation: B. Silke et al., beta-adrenoceptor modulation and heart rate variability - The value of scatterplot measures of compactness, CARDIO DRUG, 14(4), 2000, pp. 433-440
Authors:
McAuley, DF
Hanratty, CG
McGurk, C
Nugent, AG
Johnston, GD
Citation: Df. Mcauley et al., Effect of methionine supplementation on endothelial function, plasma homocysteine, and lipid peroxidation, J TOX-CLIN, 37(4), 1999, pp. 435-440
Citation: Cg. Hanratty et al., Evaluation of the effect on heart rate variability of a beta(2)-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods, BR J CL PH, 47(2), 1999, pp. 157-166
Citation: B. Silke et al., Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods, J CARDIO PH, 33(6), 1999, pp. 859-867